InsidersTradesSigma
Browse the complete record of transactions filed by Jeffrey Borcherding, 董事长兼首席执行官. Insider active across 2 companies, notably Immunovia AB (publ). Cumulatively, 1 disclosures have been published. History available since 22 May 2025. The latest transaction was disclosed on 22 May 2025 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Jeffrey Borcherding is the CEO of Immunovia AB (publ). In this role, he oversees daily operations and the implementation of the company's strategy. His experience in the biotechnology sector is essential for Immunovia.